Mar 17, 2015 - releasing hormone (GHRH) plus GH-Releasing Peptide-6, which ..... administration of GH-releasing hormone and GHRP-6: evidence for a.
Chemical Pathology, National Health Laboratory Service and Stellenbosch University, and c Faculty of Health and. Wellness Science, Cape Peninsula ...
brain (Bliss and Lynch, 1988; Gustafsson and Wigstrom, 1988;. Bliss and Collingridge ...... Hu GY, Hvalby O, Walaas SI, Albert KA, Skjeffo P, Andersen P, Green-.
Abstract. Background: mTOR inhibition of aromatase inhibitor (AI)-resistant breast cancer is currently under evaluation in the clinic. Everolimus/RAD001 ...
Jul 8, 2003 - Mónica Gordón-Alonso,1 María Angeles García-López,1 Hortensia de la Fuente,1. Carlos Martínez-A,3 Pilar Lauzurica,2 and Francisco ...
Mar 14, 2014 - Induction of Apoptosis by PKCd via Ceramide Generation. PLoS ONE 9(3): ... Protein kinase C (PKC) isotypes represent key components of.
developed in NaF-mediated oxidative injuries in rat liver (+ve) and lungs (-ve), ..... Charge-specific liposomal melatonin is shown by topography-flattened views.
Aug 20, 2015 - ¤b Current address: Department of Experimental Oncology, Regina ...... Dayton TL, Davidson SM, Fiske BP, Hosios AM, Bellinger G, et al. ... Cheong JH, Park ES, Liang J, Dennison JB, Tsavachidou D, Nguyen-Charles C, et al ...
Dec 23, 2007 - covers the use of one or more enzymes for converting electroinactive ..... 'enzyme-transistor' responsive to glucose was prepared by connecting ...
Dec 23, 2007 - Joseph Wang has been the Director of the Center for Bioelectronics and ..... (plastic or ceramic) substrates based on pressing the corre-.
Sep 14, 2000 - Debbie C. Thurmond², Silvia Mora², Satoshi Shigematsu², ..... Keller, S. R., Scott, H. M., Mastick, C. C., Aebersold, R. & Lienhard, G. E. Cloning ...
Santen Pharmaceutical, Osaka, Japan). Experimental CNV was created as described elsewhere23 with minor modifications. Laser photocoagu- lations were ...
Exogenous Glucose Administration Impairs Glucose ... › publication › fulltext › 24503059... › publication › fulltext › 24503059...by Y Watanabe · 2013 · Cited by 15 · Related articlesJun 24, 2013 — sepsis induces profound insulin resistance and im
C100. 22. Clerici, C., S. Couette, A. Loiseau, P. Herman, and C. Amiel. 1995. Evi- dence of Na-K-Cl cotransport in alveolar epithelial cells: effect of phorbol.
Abstract. Interferon regulatory factor-1 (IRF-1) is a tumor- suppressor gene induced by interferon-γ (IFNγ) and plays an important role in the cell death of ...
Aug 10, 2014 - half of control when grown in a monolayer (Figure .... expression, epithelial cells lose the ability to self-destruct when detached from the ...
Oct 2, 2013 - Editor: Ruby John Anto, Rajiv Gandhi Centre for Biotechnology, India. Received May 23, 2013; Accepted August 23, 2013; Published October 2 ...
Oct 9, 2014 - aggrecan and its degrading enzymes ADAMTS-4 and ADAMTS-5 is implicated in the development of IDD. Here, we investigated the effect of ...
Dec 16, 2009 - Professional V10.2 and rVISTA results were further analyzed .... Jurka, J. and Shaffer, L.G. (2006) Identification of sequence motifs at the.
Jan 28, 2010 - Acknowledgements. This study was supported by grants from the Samuel. Waxman Cancer Research Foundation and from the Israel Science ...
Dec 21, 2015 - interpreting the data, writing and editing the manuscript, and funding the ... previously awarded an STTR grant (R41CA180347) for developing.
Aug 29, 2013 - and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin.
Hans. Jansen, Erasmus University Rotterdam, the Netherlands) and then the activity was measured using Intralipid® labeled with glycerol-3H-oleate (American ...
Physiol. Res. 56: 175-181, 2007
Glucose Administration Downregulates Lipoprotein Lipase Activity in vivo: a Study Using Repeated Intravenous Fat Tolerance Test E. JINDŘICHOVÁ1,2, S. KRATOCHVÍLOVÁ1, J. KOVÁŘ1,2 1
Institute for Clinical and Experimental Medicine and 2Centre for Cardiovascular Research, Prague, Czech Republic Received January 26, 2006 Accepted March 22, 2006 On-line available March 23, 2006
Summary Lipoprotein lipase (LPL) is a key factor determining the clearance of triglycerides from the circulation. The enzyme activity is tissue-specifically regulated by insulin, but it is not clear yet how insulin regulates the total LPL activity in the circulation. To answer such question, we measured LPL activity using the intravenous fat tolerance test (IVFTT) that was carried out 1 h before as well as 2 h and 4 h after oral administration of glucose (75 g) in eleven healthy male volunteers. In control experiments, no glucose was given to the subjects. Glucose administration resulted in an expected increase in plasma glucose and insulin and in a suppression of non-esterified fatty acid concentration. The LPL activity assessed in IVFTT as a k2 rate constant did not change in control experiments and decreased to 78 % and 73 % of baseline values 2 h and 4 h after glucose administration, respectively (p=0.01). Similarly, LPL activity measured in the plasma after intravenous injection of heparin at the end of the experiments was 16 % lower (p